Health
Nanobody could be used as antiviral treatment against COVID-19 – Drug Target Review
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Researchers have identified a small neutralising antibody, a so-called nanobody, that they say has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19.
The study was c…
-
Noosa News17 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News18 hours agoNon-compliance, human error led to $2m Noosa Council fraud
-
General17 hours agoGold, iron ore and population swell big state’s coffers
-
General17 hours agoPALM farm worker sentenced to eight years’ jail for raping teenager near Arrawarra